Skip to main content
PMC home page
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 1999 Feb;58(2):85–89. doi: 10.1136/ard.58.2.85

Neuropsychiatric systemic lupus erythematosus is associated with imbalance in interleukin 10 promoter haplotypes

M Rood 1, V Keijsers 1, M W van der Linden 1, T Tong 1, S Borggreve 1, C Verweij 1, F Breedveld 1, T Huizinga 1
PMCID: PMC1752835  PMID: 10343522

Abstract

OBJECTIVE—To investigate the association of interleukin 10 (IL10) promoter polymorphisms and neuropsychiatric manifestations of systemic lupus erythematosus (SLE).
METHODS—IL10 haplotypes of 11 healthy volunteers were cloned to confirm that in the Dutch population, only the three common haplotypes (-1082/-819/-592) GCC, ACC and ATA exist. The IL10 promoter polymorphisms of 92 SLE patients and 162 healthy controls were determined. The medical records of the SLE patients were screened for the presence of neuropsychiatric involvement.
RESULTS—All cloned haplotypes were either GCC, ACC or ATA. Forty two SLE patients had suffered from neuropsychiatric manifestations (NP-SLE). In NP-SLE patients, the frequency of the ATA haplotype is 30% versus 18% in the controls and 17% in the non-NP-SLE group (odds ratios 1.9, p=0.02, and 2.1, p=0.04, respectively), whereas the GCC haplotype frequency is lower in the NP-SLE group compared with controls and non-NP-SLE patients (40% versus 55% and 61%, odds ratios 0.6, p=0.02 and 0.4 p=0.006). The odds ratio for the presence of NP-SLE is inversely proportional to the number of GCC haplotypes per genotype when the NP-SLE group is compared with non-NP-SLE patients.
CONCLUSIONS—The IL10 locus is associated with neuropsychiatric manifestations in SLE. This suggests that IL10 is implicated in the immunopathogenesis of neuropsychiatric manifestations in SLE.

 Keywords: systemic lupus erythematosus; neuropsychiatric manifestations; genetics; interleukin 10 promoter haplotypes

Full Text

The Full Text of this article is available as a PDF (109.6 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Block S. R., Winfield J. B., Lockshin M. D., D'Angelo W. A., Christian C. L. Studies of twins with systemic lupus erythematosus. A review of the literature and presentation of 12 additional sets. Am J Med. 1975 Oct;59(4):533–552. doi: 10.1016/0002-9343(75)90261-2. [DOI] [PubMed] [Google Scholar]
  2. Botto M., Theodoridis E., Thompson E. M., Beynon H. L., Briggs D., Isenberg D. A., Walport M. J., Davies K. A. Fc gamma RIIa polymorphism in systemic lupus erythematosus (SLE): no association with disease. Clin Exp Immunol. 1996 May;104(2):264–268. doi: 10.1046/j.1365-2249.1996.33740.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Duits A. J., Bootsma H., Derksen R. H., Spronk P. E., Kater L., Kallenberg C. G., Capel P. J., Westerdaal N. A., Spierenburg G. T., Gmelig-Meyling F. H. Skewed distribution of IgG Fc receptor IIa (CD32) polymorphism is associated with renal disease in systemic lupus erythematosus patients. Arthritis Rheum. 1995 Dec;38(12):1832–1836. doi: 10.1002/art.1780381217. [DOI] [PubMed] [Google Scholar]
  4. Eskdale J., Gallagher G., Verweij C. L., Keijsers V., Westendorp R. G., Huizinga T. W. Interleukin 10 secretion in relation to human IL-10 locus haplotypes. Proc Natl Acad Sci U S A. 1998 Aug 4;95(16):9465–9470. doi: 10.1073/pnas.95.16.9465. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Eskdale J., Wordsworth P., Bowman S., Field M., Gallagher G. Association between polymorphisms at the human IL-10 locus and systemic lupus erythematosus. Tissue Antigens. 1997 Jun;49(6):635–639. doi: 10.1111/j.1399-0039.1997.tb02812.x. [DOI] [PubMed] [Google Scholar]
  6. Hagiwara E., Gourley M. F., Lee S., Klinman D. K. Disease severity in patients with systemic lupus erythematosus correlates with an increased ratio of interleukin-10:interferon-gamma-secreting cells in the peripheral blood. Arthritis Rheum. 1996 Mar;39(3):379–385. doi: 10.1002/art.1780390305. [DOI] [PubMed] [Google Scholar]
  7. Hoffman S. A., Shucard D. W., Harbeck R. J. The immune system can affect learning: chronic immune complex disease in a rat model. J Neuroimmunol. 1998 Jun 15;86(2):163–170. doi: 10.1016/s0165-5728(98)00052-6. [DOI] [PubMed] [Google Scholar]
  8. Lazarus M., Hajeer A. H., Turner D., Sinnott P., Worthington J., Ollier W. E., Hutchinson I. V. Genetic variation in the interleukin 10 gene promoter and systemic lupus erythematosus. J Rheumatol. 1997 Dec;24(12):2314–2317. [PubMed] [Google Scholar]
  9. Llorente L., Richaud-Patin Y., Couderc J., Alarcon-Segovia D., Ruiz-Soto R., Alcocer-Castillejos N., Alcocer-Varela J., Granados J., Bahena S., Galanaud P. Dysregulation of interleukin-10 production in relatives of patients with systemic lupus erythematosus. Arthritis Rheum. 1997 Aug;40(8):1429–1435. doi: 10.1002/art.1780400810. [DOI] [PubMed] [Google Scholar]
  10. Llorente L., Richaud-Patin Y., Fior R., Alcocer-Varela J., Wijdenes J., Fourrier B. M., Galanaud P., Emilie D. In vivo production of interleukin-10 by non-T cells in rheumatoid arthritis, Sjögren's syndrome, and systemic lupus erythematosus. A potential mechanism of B lymphocyte hyperactivity and autoimmunity. Arthritis Rheum. 1994 Nov;37(11):1647–1655. doi: 10.1002/art.1780371114. [DOI] [PubMed] [Google Scholar]
  11. Llorente L., Zou W., Levy Y., Richaud-Patin Y., Wijdenes J., Alcocer-Varela J., Morel-Fourrier B., Brouet J. C., Alarcon-Segovia D., Galanaud P. Role of interleukin 10 in the B lymphocyte hyperactivity and autoantibody production of human systemic lupus erythematosus. J Exp Med. 1995 Mar 1;181(3):839–844. doi: 10.1084/jem.181.3.839. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Mehrian R., Quismorio F. P., Jr, Strassmann G., Stimmler M. M., Horwitz D. A., Kitridou R. C., Gauderman W. J., Morrison J., Brautbar C., Jacob C. O. Synergistic effect between IL-10 and bcl-2 genotypes in determining susceptibility to systemic lupus erythematosus. Arthritis Rheum. 1998 Apr;41(4):596–602. doi: 10.1002/1529-0131(199804)41:4<596::AID-ART6>3.0.CO;2-2. [DOI] [PubMed] [Google Scholar]
  13. Mok C. C., Lanchbury J. S., Chan D. W., Lau C. S. Interleukin-10 promoter polymorphisms in Southern Chinese patients with systemic lupus erythematosus. Arthritis Rheum. 1998 Jun;41(6):1090–1095. doi: 10.1002/1529-0131(199806)41:6<1090::AID-ART16>3.0.CO;2-6. [DOI] [PubMed] [Google Scholar]
  14. Rousset F., Garcia E., Defrance T., Péronne C., Vezzio N., Hsu D. H., Kastelein R., Moore K. W., Banchereau J. Interleukin 10 is a potent growth and differentiation factor for activated human B lymphocytes. Proc Natl Acad Sci U S A. 1992 Mar 1;89(5):1890–1893. doi: 10.1073/pnas.89.5.1890. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Salmon J. E., Millard S., Schachter L. A., Arnett F. C., Ginzler E. M., Gourley M. F., Ramsey-Goldman R., Peterson M. G., Kimberly R. P. Fc gamma RIIA alleles are heritable risk factors for lupus nephritis in African Americans. J Clin Invest. 1996 Mar 1;97(5):1348–1354. doi: 10.1172/JCI118552. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Silva L. M., Donadi E. A. Is immunogenetic susceptibility to neuropsychiatric systemic lupus erythematosus (SLE) different from non-neuropsychiatric SLE? Ann Rheum Dis. 1996 Aug;55(8):544–547. doi: 10.1136/ard.55.8.544. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Smyth L. J., Snowden N., Carthy D., Papasteriades C., Hajeer A., Ollier W. E. Fc gamma RIIa polymorphism in systemic lupus erythematosus. Ann Rheum Dis. 1997 Dec;56(12):744–746. doi: 10.1136/ard.56.12.744. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Song Y. W., Han C. W., Kang S. W., Baek H. J., Lee E. B., Shin C. H., Hahn B. H., Tsao B. P. Abnormal distribution of Fc gamma receptor type IIa polymorphisms in Korean patients with systemic lupus erythematosus. Arthritis Rheum. 1998 Mar;41(3):421–426. doi: 10.1002/1529-0131(199803)41:3<421::AID-ART7>3.0.CO;2-S. [DOI] [PubMed] [Google Scholar]
  19. Sturfelt G., Hellmer G., Truedsson L. TNF microsatellites in systemic lupus erythematosus-a high frequency of the TNFabc 2-3-1 haplotype in multicase SLE families. Lupus. 1996 Dec;5(6):618–622. doi: 10.1177/096120339600500611. [DOI] [PubMed] [Google Scholar]
  20. Sullivan K. E., Wooten C., Schmeckpeper B. J., Goldman D., Petri M. A. A promoter polymorphism of tumor necrosis factor alpha associated with systemic lupus erythematosus in African-Americans. Arthritis Rheum. 1997 Dec;40(12):2207–2211. doi: 10.1002/art.1780401215. [DOI] [PubMed] [Google Scholar]
  21. Tan E. M., Cohen A. S., Fries J. F., Masi A. T., McShane D. J., Rothfield N. F., Schaller J. G., Talal N., Winchester R. J. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1982 Nov;25(11):1271–1277. doi: 10.1002/art.1780251101. [DOI] [PubMed] [Google Scholar]
  22. Theofilopoulos A. N. Genetics of systemic autoimmunity. J Autoimmun. 1996 Apr;9(2):207–210. doi: 10.1006/jaut.1996.0025. [DOI] [PubMed] [Google Scholar]
  23. Truedsson L., Sturfelt G., Johansen P., Nived O., Thuresson B. Sharing of MHC haplotypes among patients with systemic lupus erythematosus from unrelated Caucasian multicase families: disease association with the extended haplotype [HLA-B8, SC01, DR17]. J Rheumatol. 1995 Oct;22(10):1852–1861. [PubMed] [Google Scholar]
  24. Turner D. M., Williams D. M., Sankaran D., Lazarus M., Sinnott P. J., Hutchinson I. V. An investigation of polymorphism in the interleukin-10 gene promoter. Eur J Immunogenet. 1997 Feb;24(1):1–8. doi: 10.1111/j.1365-2370.1997.tb00001.x. [DOI] [PubMed] [Google Scholar]
  25. Verduyn W., Doxiadis I. I., Anholts J., Drabbels J. J., Naipal A., D'Amaro J., Persijn G. G., Giphart M. J., Schreuder G. M. Biotinylated DRB sequence-specific oligonucleotides. Comparison to serologic HLA-DR typing of organ donors in eurotransplant. Hum Immunol. 1993 May;37(1):59–67. doi: 10.1016/0198-8859(93)90143-o. [DOI] [PubMed] [Google Scholar]
  26. Wu J., Edberg J. C., Redecha P. B., Bansal V., Guyre P. M., Coleman K., Salmon J. E., Kimberly R. P. A novel polymorphism of FcgammaRIIIa (CD16) alters receptor function and predisposes to autoimmune disease. J Clin Invest. 1997 Sep 1;100(5):1059–1070. doi: 10.1172/JCI119616. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES